C. Gury

945 total citations
23 papers, 592 citations indexed

About

C. Gury is a scholar working on Psychiatry and Mental health, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, C. Gury has authored 23 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 6 papers in Cardiology and Cardiovascular Medicine and 3 papers in Surgery. Recurrent topics in C. Gury's work include Schizophrenia research and treatment (9 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Electroconvulsive Therapy Studies (3 papers). C. Gury is often cited by papers focused on Schizophrenia research and treatment (9 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Electroconvulsive Therapy Studies (3 papers). C. Gury collaborates with scholars based in France, Australia and Canada. C. Gury's co-authors include Jean‐Louis Mas, Danièle Ranoux, J Fondarai, Mathieu Zuber, François‐Xavier Roux, Philippe Page, F. Nataf, P. Iaria, Sylvie Lancrenon and Élie Hantouche and has published in prestigious journals such as Journal of Affective Disorders, Neurosurgery and Acta Psychiatrica Scandinavica.

In The Last Decade

C. Gury

22 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Gury France 12 229 179 132 126 63 23 592
Kailash P. Bhatia United Kingdom 11 301 1.3× 122 0.7× 101 0.8× 114 0.9× 39 0.6× 41 621
Jeffrey S. Raskin United States 11 169 0.7× 161 0.9× 152 1.2× 96 0.8× 26 0.4× 83 546
J. Jörg Germany 9 176 0.8× 102 0.6× 45 0.3× 128 1.0× 60 1.0× 61 570
E.P.M. van Raak Netherlands 13 292 1.3× 230 1.3× 77 0.6× 31 0.2× 39 0.6× 19 523
Mark Payne United Kingdom 8 100 0.4× 201 1.1× 124 0.9× 155 1.2× 16 0.3× 23 673
Kerrie Schoffer Canada 9 261 1.1× 86 0.5× 41 0.3× 85 0.7× 28 0.4× 14 425
Feriha Özer Türkiye 15 322 1.4× 98 0.5× 82 0.6× 35 0.3× 60 1.0× 40 572
William J. Mullally United States 11 173 0.8× 153 0.9× 24 0.2× 45 0.4× 43 0.7× 15 386
Monica Storti Italy 11 85 0.4× 232 1.3× 47 0.4× 38 0.3× 38 0.6× 16 445
Per Ertzgaard Sweden 13 266 1.2× 175 1.0× 98 0.7× 112 0.9× 5 0.1× 34 660

Countries citing papers authored by C. Gury

Since Specialization
Citations

This map shows the geographic impact of C. Gury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Gury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Gury more than expected).

Fields of papers citing papers by C. Gury

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Gury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Gury. The network helps show where C. Gury may publish in the future.

Co-authorship network of co-authors of C. Gury

This figure shows the co-authorship network connecting the top 25 collaborators of C. Gury. A scholar is included among the top collaborators of C. Gury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Gury. C. Gury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rosenbaum, Dieter, et al.. (2012). Fréquence de l’hypertension résistante aux traitements et indication à la dénervation rénale. Annales de Cardiologie et d Angéiologie. 61(3). 229–233. 3 indexed citations
2.
Azorin, Jean‐Michel, Arthur Kaladjian, Hagop S. Akiskal, et al.. (2007). Validation of a Severity Threshold for the Mania Rating Scale: A Receiver-Operating Characteristic Analysis. Psychopathology. 40(6). 453–460. 5 indexed citations
3.
Jm, Azorin, Hagop S. Akiskal, Kareen K. Akiskal, et al.. (2006). Is psychosis in DSM‐IV mania due to severity? The relevance of selected demographic and comorbid social‐phobic features. Acta Psychiatrica Scandinavica. 115(1). 29–34. 14 indexed citations
4.
5.
Gury, C., et al.. (2006). Méthadone : de la pharmacocinétique à la pharmacologie clinique. L Encéphale. 32(4). 478–486. 15 indexed citations
6.
Akiskal, Hagop S., Kareen K. Akiskal, Sylvie Lancrenon, et al.. (2006). Validating the bipolar spectrum in the French National EPIDEP Study: Overview of the phenomenology and relative prevalence of its clinical prototypes. Journal of Affective Disorders. 96(3). 197–205. 83 indexed citations
7.
Gasquet, I., et al.. (2005). Patterns of prescription of four major antipsychotics: a retrospective study based on medical records of psychiatric inpatients. Pharmacoepidemiology and Drug Safety. 14(11). 805–811. 11 indexed citations
8.
Gauthé, Mathieu, Céline Goldberger, J.-P. Olié, et al.. (2005). Évaluation des troubles du métabolisme induits par les antipsychotiques atypiques chez les patients schizophrènes. L Encéphale. 31(1). 18–23. 1 indexed citations
9.
10.
11.
Gury, C.. (2004). Schizophrénie, diabète et antipsychotiques. L Encéphale. 30(4). 382–391. 12 indexed citations
12.
Peretti, Charles-Siegfried, et al.. (2004). P.2.115 The schizophrenia quality of life scale (SOL)42-item short form (SOL-42): Conceptual framework and item selection. European Neuropsychopharmacology. 14. S283–S283. 1 indexed citations
13.
Simon, Laurent, et al.. (2003). Pharmacologie et toxicologie cliniques de l'ecstasy. L information psychiatrique. 79(3). 233–242. 1 indexed citations
14.
Gury, C., David Ames, A. John Camm, et al.. (2003). Comment minimiser les risques associés à un allongement significatif de l’intervalle QTc chez les personnes souffrant de schizophrénie.Recommandations consensuelles du Cardiac safety in schizophrenia group. Journal de Pharmacie Clinique. 22(1). 8–17. 1 indexed citations
15.
Gury, C., et al.. (2002). Risk of QT prolongated and torsade de pointes induced by antipsychotics. Journal de Pharmacie Clinique. 21(1). 47–55. 1 indexed citations
16.
Ranoux, Danièle, C. Gury, J Fondarai, Jean‐Louis Mas, & Mathieu Zuber. (2002). Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia.. PubMed. 72(4). 459–62. 194 indexed citations
17.
Gury, C., et al.. (2001). [Antipsychotic drugs and cardiovascular safety: current studies of prolonged QT interval and risk of ventricular arrhythmia].. PubMed. 26(6). 62–72. 47 indexed citations
18.
Gairard, A., et al.. (2001). Phase IV clinical trial setting : efficacy study of midodrine in orthostatic hypotension induced by psychotropic drugs. Journal de Pharmacie Clinique. 19(4). 1 indexed citations
19.
Gury, C., et al.. (2000). [Pharmacokinetics of SSRI antidepressants: half-life and clinical applicability].. PubMed. 25(5). 470–6. 18 indexed citations
20.
Gury, C., et al.. (1995). [Leponex: experience of the hospital pharmacist].. PubMed. 21 Spec No 3. 28–32. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kailash P. Bhatia Breakdown of academic impact, for papers by Jeffrey S. Raskin Breakdown of academic impact, for papers by J. Jörg Breakdown of academic impact, for papers by E.P.M. van Raak Breakdown of academic impact, for papers by Mark Payne Breakdown of academic impact, for papers by Kerrie Schoffer Breakdown of academic impact, for papers by Feriha Özer Breakdown of academic impact, for papers by William J. Mullally Breakdown of academic impact, for papers by Monica Storti Breakdown of academic impact, for papers by Per Ertzgaard
Rankless by CCL
2026